The suppression of EZH2 results in the downregulation of critical molecules and markers associated with EMT along the STAT3/VEGFR2 axis, while concurrently bolstering the expression of E-cadherin in HNSCC cells. The gene discussed is STAT3; the disease is head and neck squamous cell carcinoma.